Ascendis will certainly get as much as USD 285 million ahead of time along with advancement and regulative landmark repayments from Novo Nordisk.
发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/novo-nordisk-and-ascendis-partner-to-develop-once-monthly-obesity-and-diabetes-treatment/